Silexion Therapeutics Ltd. (SLXN) Financials

SLXN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 4.6 million 4.3 million
Dec. 31, 2025 7.2 million 4.6 million
Sept. 30, 2025 11.6 million 4.6 million
June 30, 2025 5.8 million 5.7 million

SLXN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.6 million 345000
Dec. 31, 2025 -3.0 million 38000
Sept. 30, 2025 -2.8 million 38000
June 30, 2025 -2.5 million 37000

SLXN Net Income

No data available :(

SLXN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.4 million 251000 -
Dec. 31, 2025 6.0 million 286000 468000
Sept. 30, 2025 9.2 million 311000 485000
June 30, 2025 3.5 million 3.2 million 508000

SLXN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 3.2 million
Dec. 31, 2025 3.1 million
Sept. 30, 2025 1.1 million
June 30, 2025 579523

SLXN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 1.4 million 1.4 million -
Dec. 31, 2025 2000 3.4 million 1.0 million -
Sept. 30, 2025 - 2.2 million 1.1 million -
June 30, 2025 1000 1.0 million 1.3 million -

SLXN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 2000
Dec. 31, 2025 - 3000
Sept. 30, 2025 - 4000
June 30, 2025 - 3000

SLXN

Price: $2.73

52 week price:
2.31
223.60

Earnings Per Share: -8.96 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 2.0 million

Links: